Brazilian Supreme Court Refuses To Judge Its Biggest Case On IP And Access To Medicines, And Benefits Big Pharma With Undue Monopolies
The Brazilian Supreme Court (STF) has mysteriously cancelled the judgment of the most important case regarding intellectual property and health ever to be decided by the court.
Intellectual Property Watch | 13 September, 2018
SECTION27, TAC launch new treatment access history
On the 26th of July at the International AIDS conference, hosted in the Netherlands, SECTION27 and the Treatment action campaign (TAC) launched a new publication documenting the history of the access to medicines movement in South Africa.
Section27.og | 03 September, 2018
ABIA and GTPI on Globo Radio in Brazil, on their demands for the last standing Sofosbuvir patent application to be rejected
The objective is that the INPI (National Institute of Industrial Property) does not grant the patent registry to an American laboratory for an essential remedy in the treatment of the disease.
Globo Radio | 20 August, 2018
Why India’s IP policy needs a South African tweak
It is unplugged from existing health and science & technology policies. South Africa recently adopted a new Intellectual Property Policy, which seeks to align IP with the country’s national development plan.
The Hindu Business Line | 20 July, 2018
இந்தியாவில் மருந்து காப்புரிமை முறைப்படிதான் வழங்கப்படுகிறதா?
An article on the accessibsa project’s work in The Hindu (Tamil edition)